9 in Pediatric Blood & Cancer. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR ...

Highlights in acute lymphoblastic leukemia (ALL), presented at the American ... BLIN improved outcomes for children with standard-risk B-cell ALL (B-ALL) at average or higher risk for relapse.

The European Commission (EC) has approved Blincyto (blinatumomab) monotherapy as part of consolidation therapy for the treatment of adults with newly-diagnosed Philadelphia chromosome-negative ...

The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.

A YOUNG girl suffering from cancer lived out her dream after being whisked away on a magical trip to Paris. Cork native Ava ...

City of Hope conducted RNAseq analysis of patient samples with B-cell acute lymphoblastic leukemia (B-ALL), which revealed that among the m6A machinery genes, YTHDF2, which encodes YTH ...

12, 2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

Some children and young people up the age of 25 years have a type of CAR T-cell therapy called tisagenlecleucel (Kymriah). It is for a type of leukaemia called B cell acute lymphoblastic leukaemia (B ...

Braden Smith had a big night statistically Friday against Michigan. But it pales in comparison to the dollar figure his ...

Hammer Down Cancer game featured player-worn jerseys auctioned off for cancer research, and coaches' shoes will be auctioned ...